133 results in Exploration of Musculoskeletal Diseases
Most Downloaded
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
A survey of the composition, safety, efficacy and regulation of non-autologous biologic treatments in human musculoskeletal pathologies
Theodore Sand
Published: June 25, 2025 Explor Musculoskeletal Dis. 2025;3:100795
This article belongs to the special issue Innovation in Orthopedics
4761 34 0
Open Access Review
The reality of sonography of the infant hip in Brazil: results and recommendations
Giovanna Galvão Braga Motta ... Alexandre Francisco de Lourenço
Published: May 20, 2024 Explor Musculoskeletal Dis. 2024;2:156–163
3898 33 2
Open Access Commentary
Should all people starting urate-lowering therapy for gout receive anti-inflammatory prophylaxis?
Edward Roddy ... Christian D. Mallen
Published: November 15, 2024 Explor Musculoskeletal Dis. 2024;2:521–528
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
13495 33 0
Open Access Perspective
Opportunities of digital health technologies for rheumatology: from clinics to quality and research
Michael Schirmer ... Johannes D. Pallua
Published: April 08, 2024 Explor Musculoskeletal Dis. 2024;2:82–91
4209 32 1
Open Access Original Article
Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone
Ioana Hotea ... Tim L. Jansen
Published: August 30, 2023 Explor Musculoskeletal Dis. 2023;1:97–105
7799 32 3
Open Access Original Article
Evaluation of continued 2-monthly or annual urate monitoring in gout: an extension of the GoutSMART randomised controlled feasibility trial
Philip L. Riches ... Amrey Krause
Published: November 11, 2024 Explor Musculoskeletal Dis. 2024;2:509–520
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
5045 32 0
Open Access Review
Urate lowering therapy in primary care: rheum for improvement
Emilie Schurenberg ... Kenneth G. Saag
Published: March 25, 2025 Explor Musculoskeletal Dis. 2025;3:100788
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
11765 32 0
Open Access Perspective
Causal inference methods for evaluating comparative effectiveness: target trial emulation
Tobias Haugegaard, Robin Christensen
Published: August 05, 2026 Explor Musculoskeletal Dis. 2026;4:1007132
398 34 0
Open Access Original Article
Sex differences in response to rehabilitation treatment for musculoskeletal pain: the mediating role of post-traumatic stress symptoms
Antonina D.S. Pavilanis ... Michael J.L. Sullivan
Published: June 26, 2024 Explor Musculoskeletal Dis. 2024;2:242–255
4697 31 1
Open Access Original Article
Prevalence and factors associated to diffuse idiopathic skeletal hyperostosis in gout
Fernando Pérez-Ruiz ... Ana María Herrero-Beites
Published: September 27, 2023 Explor Musculoskeletal Dis. 2023;1:121–127
4207 31 1
Open Access Case Report
Participatory action ultrasound imaging in increasing clinician confidence with new approaches to trigger point dry needling of the lateral pterygoid
Andrew Ball ... Jordan Spennato
Published: February 05, 2024 Explor Musculoskeletal Dis. 2024;2:49–55
5768 31 0
Open Access Review
The impact of social media and online communities of practice in rheumatology
Judy L. Seraphine, Alvin F. Wells
Published: October 30, 2024 Explor Musculoskeletal Dis. 2024;2:478–489
5923 31 2
Open Access Mini Review
Long noncoding RNA: control of chromatin structure in muscle differentiation
Rodolfo Daniel Ávila-Avilés
Published: August 19, 2025 Explor Musculoskeletal Dis. 2025;3:1007101
3918 31 1
Open Access Original Article
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study
Fanny Alcira Reyes Neira ... Andrea Yukie Shimabuco
Published: February 10, 2025 Explor Musculoskeletal Dis. 2025;3:100783
5099 30 3
Open Access Review
Calcium pyrophosphate deposition disease: points to be considered for quality assurance in clinical practice
Michael Schirmer, Johannes Dominikus Pallua
Published: July 18, 2024 Explor Musculoskeletal Dis. 2024;2:270–278
This article belongs to the special issue Calcium Pyrophosphate Deposition Disease
8051 30 1
Open Access Original Article
Factors associated with interstitial lung disease in patients with rheumatoid arthritis
Benyapa Suppa-Udom ... Wanruchada Katchamart
Published: September 14, 2024 Explor Musculoskeletal Dis. 2024;2:431–442
5117 29 0
Open Access Original Article
Progression of arthritis after four-corner fusion in patients with calcium pyrophosphate deposition disease: a case series of eleven patients
John F. Hoy ... Xavier C. Simcock
Published: July 10, 2024 Explor Musculoskeletal Dis. 2024;2:256–263
This article belongs to the special issue Calcium Pyrophosphate Deposition Disease
5202 29 2
Open Access Mini Review
Lycopene supplementation in rheumatic diseases: a comprehensive review
Jozélio Freire de Carvalho, Ana Tereza Amoedo Martinez
Published: December 09, 2025 Explor Musculoskeletal Dis. 2025;3:1007112
3742 29 2
Open Access Original Article
Lessons to be learned from real life data based on 98 gout patients using benzbromarone
Ioana Hotea ... Tim L. Jansen
Published: October 30, 2023 Explor Musculoskeletal Dis. 2023;1:171–179
10779 28 1
Open Access Original Article
Measuring itch occurrence in various chronic pain conditions: across sectional study
Wael Saleem, Marco Marcus
Published: April 10, 2024 Explor Musculoskeletal Dis. 2024;2:106–115
4069 27 0